LeBlanc, R., Mian, H., Reece, D., Su, J., Masih-Khan, E., Chu, M., Jimenez-Zepeda, V., Sebag, M., Song, K., Louzada, M., Kotb, R., Visram, A., White, D., Stakiw, J., Reiman, A., Aslam, M., Bergstrom, D., Kaedbey, R., Gul, E., & Venner, C. (2023). Outcome of carfilzomib/pomalidomide-based regimens after daratumumab-based treatment in relapsed multiple myeloma: A Canadian Myeloma Research Group Database analysis. European Journal of Haematology, 111(5), 815-823. https://doi.org/10.1111/ejh.14082
Outcome of carfilzomib/pomalidomide-based regimens after daratumumab-based treatment in relapsed multiple myeloma: A Canadian Myeloma Research Group Database analysis. / LeBlanc, Richard; Mian, Hira; Reece, Donna et al.
In:
European Journal of Haematology, Vol. 111, No. 5, 11.2023, p. 815-823.
Research output: Contribution to journal › Article › peer-review
LeBlanc, R, Mian, H, Reece, D, Su, J, Masih-Khan, E, Chu, M, Jimenez-Zepeda, V, Sebag, M, Song, K, Louzada, M, Kotb, R, Visram, A, White, D, Stakiw, J, Reiman, A, Aslam, M, Bergstrom, D, Kaedbey, R, Gul, E & Venner, C 2023, 'Outcome of carfilzomib/pomalidomide-based regimens after daratumumab-based treatment in relapsed multiple myeloma: A Canadian Myeloma Research Group Database analysis', European Journal of Haematology, vol. 111, no. 5, pp. 815-823. https://doi.org/10.1111/ejh.14082
LeBlanc R, Mian H, Reece D, Su J, Masih-Khan E, Chu M et al. Outcome of carfilzomib/pomalidomide-based regimens after daratumumab-based treatment in relapsed multiple myeloma: A Canadian Myeloma Research Group Database analysis. European Journal of Haematology. 2023 Nov;111(5):815-823. doi: 10.1111/ejh.14082
LeBlanc, Richard ; Mian, Hira ; Reece, Donna et al. / Outcome of carfilzomib/pomalidomide-based regimens after daratumumab-based treatment in relapsed multiple myeloma : A Canadian Myeloma Research Group Database analysis. In: European Journal of Haematology. 2023 ; Vol. 111, No. 5. pp. 815-823.
@article{42ad73a427bd4c0ba9ac8aa302283030,
title = "Outcome of carfilzomib/pomalidomide-based regimens after daratumumab-based treatment in relapsed multiple myeloma: A Canadian Myeloma Research Group Database analysis",
keywords = "carfilzomib, multiple myeloma, pomalidomide, post-daratumumab, real-world data",
author = "Richard LeBlanc and Hira Mian and Donna Reece and Jiandong Su and Esther Masih-Khan and Michael Chu and Victor Jimenez-Zepeda and Michael Sebag and Kevin Song and Martha Louzada and Rami Kotb and Alissa Visram and Darrell White and Julie Stakiw and Antony Reiman and Muhammad Aslam and Debra Bergstrom and Rayan Kaedbey and Engin Gul and Christopher Venner",
note = "Publisher Copyright: {\textcopyright} 2023 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.",
year = "2023",
month = nov,
doi = "10.1111/ejh.14082",
language = "English",
volume = "111",
pages = "815--823",
journal = "European Journal of Haematology",
issn = "0902-4441",
publisher = "Wiley-Blackwell",
number = "5",
}
TY - JOUR
T1 - Outcome of carfilzomib/pomalidomide-based regimens after daratumumab-based treatment in relapsed multiple myeloma
T2 - A Canadian Myeloma Research Group Database analysis
AU - LeBlanc, Richard
AU - Mian, Hira
AU - Reece, Donna
AU - Su, Jiandong
AU - Masih-Khan, Esther
AU - Chu, Michael
AU - Jimenez-Zepeda, Victor
AU - Sebag, Michael
AU - Song, Kevin
AU - Louzada, Martha
AU - Kotb, Rami
AU - Visram, Alissa
AU - White, Darrell
AU - Stakiw, Julie
AU - Reiman, Antony
AU - Aslam, Muhammad
AU - Bergstrom, Debra
AU - Kaedbey, Rayan
AU - Gul, Engin
AU - Venner, Christopher
N1 - Publisher Copyright:
© 2023 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
PY - 2023/11
Y1 - 2023/11
KW - carfilzomib
KW - multiple myeloma
KW - pomalidomide
KW - post-daratumumab
KW - real-world data
UR - http://www.scopus.com/inward/record.url?scp=85167708603&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85167708603&partnerID=8YFLogxK
U2 - 10.1111/ejh.14082
DO - 10.1111/ejh.14082
M3 - Article
C2 - 37574220
AN - SCOPUS:85167708603
SN - 0902-4441
VL - 111
SP - 815
EP - 823
JO - European Journal of Haematology
JF - European Journal of Haematology
IS - 5
ER -